QT
KMTS

Quantbot Technologies’s Kestra Medical Technologies KMTS Stock Holding History

Quantbot Technologies’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,640
Closed -$150K – 2258
2025
Q4 		$150K Buy
5,640
+5,611
+19,348% +$145K 0.01% 1318
2025
Q3 		$689 Buy
+29
New +$519 ﹤0.01% 1673

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Quantbot Technologies's KMTS Position: Q1 2026 in Review

Quantbot Technologies sold out of Kestra Medical Technologies (KMTS) in Q1 2026, closing a stake of 5,640 shares — an estimated $150K sold.

Quantbot Technologies first reported a position in KMTS in Q3 2025 and held it in 2 quarters. The position peaked at $150K in Q4 2025. 103 funds tracked by Wall St. Rank hold KMTS as of Q1 2026.

  • Quantbot Technologies reported no remaining Kestra Medical Technologies position as of Q1 2026 after selling out during the quarter.
  • Quantbot Technologies sold 5,640 Kestra Medical Technologies shares in Q1 2026, an estimated $150K.
  • Quantbot Technologies first reported a position in Kestra Medical Technologies in Q3 2025 and held it in 2 quarters.
  • Quantbot Technologies's Kestra Medical Technologies position peaked at $150K in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q1 2026.

Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.